Litcius/Paper detail

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial

Tatjana Welzel, Andrew Atkinson, Nina Schöbi, Maya C. André, Douggl G. N. Bailey, Géraldine Blanchard‐Rohner, Michael Buettcher, Serge Grazioli, Henrik Koehler, Marie‐Hélène Perez, Johannes Trück, Federica Vanoni, Petra Zimmermann, Carlos Sanchez, Julia Bielicki, Luregn J. Schlapbach, Andreas Bieri, Spyridoula Gysi, Indra Janz, Birgit Donner, Jürg Hammer, Ulrich Heininger, Malte Kohns Vasconcelos, Nicole Mettauer, Alexandra Meyer, Diana Reppucci, Chloé Schlaeppi, Daniel Trachsel, Nina Vaezipour, Clemens von Kalckreuth, Andreas Woerner, Andreas Zutter, Lisa Kottanattu, Calogero Mazzara, Alessia Severi Conti, Christoph Aebi, Philipp Agyeman, Andrea Duppenthaler, Martin Glöckler, Sabine Pallivathukal, Thomas Riedel, Hong-Phuc Cudré-Cung, Mladen Pavlović, Alice Bordessoule, Arnaud G. L’Huillier, Anne‐Laure Martin, Angelo Polito, Marie Rohr, María I. Rodríguez, Noémie Wagner, Vivianne Chanez, Sabrina Bressieux-Degueldre, Thomas Ferry, Michaël Hofer, David Longchamp, Julia Natterer, Rebecca D. Oppenheim, Alex Donas, Sara Germann, Katja Hrup, Daniela Kaiser, Hans Peter Kuen, Michaela Lütolf Erni, Katharina Schwendener Scholl, Janine Stritt, Katharina Wechselberger, Ingrid A. Beck, André Birkenmaier, Martin Flade, Bjarte Rogdo, Ivo Iglowstein, Philip Lorenz, Tanja Wachinger, Konstanze Zöhrer, Barbara Brotschi, Patrick M. Meyer Sauteur, Jana Pachlopnik Schmid, Seraina Prader, Michelle Seiler, Kathrin Weber, Daniela Wütz, Elizabeth Whittaker, Saul N. Faust

2023The Lancet Child & Adolescent Health40 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMethylprednisoloneRandomized controlled trialPopulationClinical trialInternal medicinePediatricsEnvironmental healthKawasaki Disease and Coronary ComplicationsCOVID-19 Clinical Research StudiesRespiratory viral infections research
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial | Litcius